Company Filing History:
Years Active: 2017
Title: Kavita Dhodapkar: Innovator in Cancer Immunotherapy
Introduction
Kavita Dhodapkar is a prominent inventor based in New Haven, CT (US). She has made significant contributions to the field of cancer immunotherapy, focusing on the development of predictive biomarkers and innovative vaccine strategies. With a total of 2 patents, her work is paving the way for advancements in cancer treatment.
Latest Patents
Kavita's latest patents include groundbreaking inventions that aim to enhance the effectiveness of immunotherapy for cancer patients. The first patent, titled "Immune biomarkers and assays predictive of clinical response to immunotherapy for cancer," relates to predictors of a cancer patient's responsiveness to immunotherapy. The second patent, "Immunogenic epitopes as targets for universal cancer vaccines," provides a peptide with a specific amino acid sequence that can be used as a vaccine, showcasing her innovative approach to cancer treatment.
Career Highlights
Kavita Dhodapkar is affiliated with Yale University, where she conducts her research and develops her inventions. Her work has garnered attention in the scientific community, contributing to the understanding of cancer immunology and the development of new therapeutic strategies.
Collaborations
Kavita collaborates with her coworker, Madhav Dhodapkar, further enhancing the research efforts in their field. Their combined expertise is instrumental in advancing the understanding of cancer treatment and immunotherapy.
Conclusion
Kavita Dhodapkar's contributions to cancer immunotherapy through her patents and research at Yale University highlight her role as an innovator in the field. Her work continues to inspire advancements in cancer treatment and patient care.